Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Avelumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Avelumabmarket, defines the market attractiveness level of Avelumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Avelumab industry, describes the types of Avelumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Avelumab market and the development prospects and opportunities of Avelumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Avelumab market in Chapter 13.
By Player:
Pfizer
Merck
By Type:
Injection
By End-User:
Merkel-cell Carcinoma
Non-small Cell Lung Carcinoma (NSCLC)
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Avelumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Avelumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Avelumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Avelumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Avelumab Market Analysis and Outlook to 2022
-
7.1 Global Avelumab Consumption (2017-2022)
-
7.2 United States Avelumab Consumption (2017-2022)
-
7.3 Europe Avelumab Consumption (2017-2022)
-
7.4 China Avelumab Consumption (2017-2022)
-
7.5 Japan Avelumab Consumption (2017-2022)
-
7.6 India Avelumab Consumption (2017-2022)
-
7.7 South Korea Avelumab Consumption (2017-2022)
8 Region and Country-wise Avelumab Market Analysis and Outlook to 2028
-
8.1 Global Avelumab Consumption Forecast (2022-2028)
-
8.2 United States Avelumab Consumption Forecast (2022-2028)
-
8.3 Europe Avelumab Consumption Forecast (2022-2028)
-
8.4 China Avelumab Consumption Forecast (2022-2028)
-
8.5 Japan Avelumab Consumption Forecast (2022-2028)
-
8.6 India Avelumab Consumption Forecast (2022-2028)
-
8.7 South Korea Avelumab Consumption Forecast (2022-2028)
9 Global Avelumab Market Outlook by Types and Applications to 2022
-
9.1 Global Avelumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Avelumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Merkel-cell Carcinoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Non-small Cell Lung Carcinoma (NSCLC) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Avelumab Market Outlook by Types and Applications to 2028
-
10.1 Global Avelumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Avelumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Merkel-cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Non-small Cell Lung Carcinoma (NSCLC) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Avelumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Avelumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Avelumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Avelumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Avelumab Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Avelumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Avelumab Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Avelumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Avelumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Avelumab
-
Figure Avelumab Picture
-
Table Global Avelumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Avelumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Avelumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Avelumab Consumption by Country (2017-2022)
-
Figure United States Avelumab Consumption and Growth Rate (2017-2022)
-
Table Europe Avelumab Consumption and Growth Rate (2017-2022)
-
Figure China Avelumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Avelumab Consumption and Growth Rate (2017-2022)
-
Figure India Avelumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Avelumab Consumption and Growth Rate (2017-2022)
-
Figure Global Avelumab Consumption Forecast by Country (2022-2028)
-
Figure United States Avelumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Avelumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Avelumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Avelumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Avelumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Avelumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Merkel-cell Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Non-small Cell Lung Carcinoma (NSCLC) Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Merkel-cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-small Cell Lung Carcinoma (NSCLC) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Avelumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Avelumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Avelumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Avelumab Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Avelumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Avelumab Product and Service
-
